IMPROVEMENT IN FATIGUE WITH MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Miguel Reguiero  1     Monika Fischer  2     David T. Rubin  3     Toshifumi Hibi  4     Peter Bossuyt  5     Pascal Juillerat  6     Paul Pollack  7     Xian Zhou  8     Marijana Protic  9     Theresa Hunter Gibble  10     Lai Shan Chan  10     Hilde Carlier  11     Pieter Hindryckx  12    
1 Cleveland Clinic, Cleveland, United States
2 IUPUI, Indianapolis, United States
3 University of Chicago Medicine, Chicago, United States
4 Kitasato Institute Hospital IBD Research and Treatment, Tokyo, Japan
5 Imelda General Hospital, Bonheiden, Belgium
6 Inselspital Bern University Clinic for Visceral Surgery and Medicin, Bern, Switzerland
7 Consultant, Bexley, OH, United States
8 Syneos Health, Morrisville, United States
9 Eli Lilly & Company, Vernier, Genève
10 Eli Lilly and Company, Indianapolis, United States
11 Eli Lilly and Company, Brussels, Belgium
12 Ghent University Hospital Dept. of Gastroenterology, Ghent, Belgium

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing